J. Rosenblat

Nelson B Rodrigues, R. McIntyre, J. Rosenblat, 2021, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

Oral Ketamine for Depression: A Systematic Review.

R. McIntyre, J. Rosenblat, Yena Lee, 2019, The Journal of clinical psychiatry.

Bipolar Disorder and Inflammation.

R. McIntyre, J. Rosenblat, 2016, The Psychiatric clinics of North America.

Pharmacologic implications of inflammatory comorbidity in bipolar disorder.

R. McIntyre, J. Rosenblat, J. Gregory, 2016, Current opinion in pharmacology.

Parental characteristics and the risk of schizophrenia in a Chinese population: a case-control study

R. McIntyre, J. Rosenblat, Q. Lu, 2019, Nordic journal of psychiatry.

Efficacy and tolerability of minocycline for depression: A systematic review and meta-analysis of clinical trials.

R. McIntyre, J. Rosenblat, 2018, Journal of affective disorders.

Leptin, obesity, and response to ketamine

R. McIntyre, J. Rosenblat, R. Mansur, 2020, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

Evaluating the Use of Glucagon-Like Peptide 1 for the Treatment of Cognitive Dysfunction in Individuals with Mood Disorders

Nelson B Rodrigues, R. McIntyre, J. Rosenblat, 2022, Current Treatment Options in Psychiatry.

Cognitive Deficits as a Mediator of Poor Occupational Function in Remitted Major Depressive Disorder Patients

R. McIntyre, J. Rosenblat, Ron Kakar, 2016, Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology.

Predicting antidepressant response using early changes in cognition: A systematic review

R. McIntyre, J. Rosenblat, E. Brietzke, 2018, Behavioural Brain Research.

Cognitive impairment as measured by the THINC-integrated tool (THINC-it): Association with psychosocial function in major depressive disorder.

Nicole E. Carmona, B. Baune, R. Lam, 2017, Journal of affective disorders.

Trace amine-associated receptor 1 (TAAR1): Potential application in mood disorders: A systematic review

R. McIntyre, J. Rosenblat, F. Nasri, 2021, Neuroscience & Biobehavioral Reviews.

The Effect of Loneliness on Distinct Health Outcomes: A Comprehensive Review and Meta-Analysis

R. McIntyre, J. Rosenblat, R. Ho, 2020, Psychiatry Research.

Pharmacological interventions targeting anhedonia in patients with major depressive disorder: A systematic review

R. McIntyre, J. Rosenblat, E. Brietzke, 2019, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

Changes in symptoms of anhedonia in adults with major depressive or bipolar disorder receiving IV ketamine: Results from the Canadian Rapid Treatment Center of Excellence.

Nelson B Rodrigues, R. McIntyre, J. Rosenblat, 2020, Journal of affective disorders.

Comparing mortality from covid-19 to mortality due to overdose: A micromort analysis

R. McIntyre, J. Rosenblat, E. Brietzke, 2021, Journal of Affective Disorders.

Suicide reduction in Canada during the COVID-19 pandemic: lessons informing national prevention strategies for suicide reduction

R. McIntyre, R. Ho, J. Rosenblat, 2021, Journal of the Royal Society of Medicine.

Onset and frequency of depression in post-COVID-19 syndrome: A systematic review

R. McIntyre, J. Rosenblat, R. Ho, 2021, Journal of Psychiatric Research.

Probiotics for the treatment of depressive symptoms: An anti-inflammatory mechanism?

R. McIntyre, J. Rosenblat, E. Brietzke, 2018, Brain, Behavior, and Immunity.

Molecular Mechanisms of Psilocybin and Implications for the Treatment of Depression

Nelson B Rodrigues, R. McIntyre, J. Rosenblat, 2021, CNS Drugs.

Fatigue and cognitive impairment in Post-COVID-19 Syndrome: A systematic review and meta-analysis

Nelson B Rodrigues, R. McIntyre, M. Vinberg, 2021, Brain, Behavior, and Immunity.

The glycine site of NMDA receptors: A target for cognitive enhancement in psychiatric disorders

R. McIntyre, J. Rosenblat, E. Brietzke, 2019, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

Efficacy of Adjunctive Infliximab vs Placebo in the Treatment of Adults With Bipolar I/II Depression: A Randomized Clinical Trial.

Nicole E. Carmona, R. McIntyre, J. Rosenblat, 2019, JAMA psychiatry.

Exploring brain insulin resistance in adults with bipolar depression using extracellular vesicles of neuronal origin.

Nelson B Rodrigues, T. Suppes, A. Fagiolini, 2020, Journal of psychiatric research.

Therapeutic potential of JAK/STAT pathway modulation in mood disorders

Roger S. McIntyre, Renee-Marie Ragguett, Joshua D. Rosenblat, 2018, Reviews in the neurosciences.

Drug-drug interactions as a result of co-administering Δ9-THC and CBD with other psychotropic agents

Nicole E. Carmona, R. McIntyre, J. Rosenblat, 2018, Expert opinion on drug safety.

Ketogenic diet as a metabolic therapy for mood disorders: Evidence and developments

R. McIntyre, M. Vinberg, J. Rosenblat, 2018, Neuroscience & Biobehavioral Reviews.

Medical comorbidity in bipolar disorder: The link with metabolic-inflammatory systems.

R. McIntyre, J. Rosenblat, Ron Kakar, 2017, Journal of affective disorders.

The neurodevelopmental basis of bipolar disorder: Mechanisms and implications

J. Rosenblat, M. Husain, S. Kloiber, 2021 .

Neurodevelopmental pathways in bipolar disorder

A. Carvalho, J. Soares, M. Berk, 2020, Neuroscience & Biobehavioral Reviews.

The Mental Health Effects of COVID-19 on Health Care Providers in China.

R. McIntyre, J. Rosenblat, R. Mansur, 2020, The American journal of psychiatry.

Inflamed moods: A review of the interactions between inflammation and mood disorders

R. McIntyre, J. Rosenblat, D. Cha, 2014, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

Ketamine-induced urological toxicity: potential mechanisms and translation for adults with mood disorders receiving ketamine treatment

Nelson B Rodrigues, R. McIntyre, J. Rosenblat, 2021, Psychopharmacology.

Metabolic-Inflammation Aspects of Depression and Cardiovascular Disease

R. McIntyre, J. Rosenblat, Ron Kakar, 2016 .

Serum metabolic profiling using small molecular water‐soluble metabolites in individuals with schizophrenia: A longitudinal study using a pre–post‐treatment design

R. McIntyre, J. Rosenblat, E. Brietzke, 2018, Psychiatry and clinical neurosciences.

Development and implementation of guidelines for the management of depression: a systematic review

N. Chavannes, W. Nolen, M. Owolabi, 2020, Bulletin of the World Health Organization.

Efficacy of antidepressants on measures of workplace functioning in major depressive disorder: A systematic review.

Nicole E. Carmona, R. McIntyre, J. Rosenblat, 2018, Journal of affective disorders.

Bipolar disorders

A. Young, A. Nierenberg, R. McIntyre, 2020, The Lancet.

Mapping inflammation onto mood: Inflammatory mediators of anhedonia

R. McIntyre, W. Swardfager, J. Rosenblat, 2016, Neuroscience & Biobehavioral Reviews.

Bipolar Disorder and Immune Dysfunction: Epidemiological Findings, Proposed Pathophysiology and Clinical Implications

R. McIntyre, J. Rosenblat, 2017, Brain sciences.

Inflammation as a neurobiological substrate of cognitive impairment in bipolar disorder: Evidence, pathophysiology and treatment implications.

R. McIntyre, J. Rosenblat, E. Brietzke, 2015, Journal of affective disorders.

Depressive disorders: Processes leading to neurogeneration and potential novel treatments

R. McIntyre, J. Rosenblat, R. Hardeland, 2018, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

Evaluating the neural substrates of effort-expenditure for reward in adults with major depressive disorder and obesity

Nelson B Rodrigues, C. Hawco, R. McIntyre, 2023, Psychiatry Research: Neuroimaging.

The impact of overweight/obesity on monetary reward processing: A systematic review.

Nelson B Rodrigues, R. McIntyre, J. Rosenblat, 2021, Journal of psychiatric research.

Expert Consensus on Screening and Assessment of Cognition in Psychiatry

Philip D. Harvey, A. Young, S. Stahl, 2019, CNS Spectrums.

Frequency analysis of symptomatic worsening following ketamine infusions for treatment resistant depression in a real-world sample: Results from the canadian rapid treatment center of excellence

Nelson B Rodrigues, R. McIntyre, J. Rosenblat, 2021, Psychiatry Research.

Hallucinogen persisting perceptual disorder: a scoping review covering frequency, risk factors, prevention, and treatment

R. McIntyre, J. Rosenblat, R. Ho, 2022, Expert opinion on drug safety.

Therapeutic Angiogenesis by Ultrasound-Mediated MicroRNA-126-3p Delivery

J. Rosenblat, H. Leong-Poi, M. Kuliszewski, 2015, Arteriosclerosis, thrombosis, and vascular biology.

Efficacy of ketamine and esketamine on functional outcomes in treatment-resistant depression: A systematic review.

Nelson B Rodrigues, R. McIntyre, J. Rosenblat, 2021, Journal of affective disorders.

Association Between Mood Disorders and Risk of COVID-19 Infection, Hospitalization, and Death: A Systematic Review and Meta-analysis.

R. McIntyre, J. Rosenblat, R. Ho, 2021, JAMA psychiatry.

Government response moderates the mental health impact of COVID-19: A systematic review and meta-analysis of depression outcomes across countries

Nelson B Rodrigues, R. McIntyre, J. Rosenblat, 2021, Journal of Affective Disorders.

The THINC-it Tool for Cognitive Assessment and Measurement in Major Depressive Disorder: Sensitivity to Change

Tanya B. Tran, R. McIntyre, J. Rosenblat, 2020, Frontiers in Psychiatry.

Assessing and measuring cognitive function in major depressive disorder

R. McIntyre, J. Rosenblat, Ron Kakar, 2016, Evidence-Based Mental Health.

Soluble TREM2 changes during the clinical course of Alzheimer’s disease: A meta-analysis

R. McIntyre, J. Rosenblat, Bing Cao, 2018, Neuroscience Letters.

The effect of pharmacogenomic testing on response and remission rates in the acute treatment of major depressive disorder: A meta-analysis.

R. McIntyre, J. Rosenblat, Yena Lee, 2018, Journal of affective disorders.

COVID-19 vaccination for the prevention and treatment of long COVID: A systematic review and meta-analysis

Nelson B Rodrigues, R. McIntyre, J. Rosenblat, 2023, Brain, Behavior, and Immunity.

Barriers, benefits and interventions for improving the delivery of telemental health services during the coronavirus disease 2019 pandemic: a systematic review

R. McIntyre, J. Rosenblat, Ashley N. Siegel, 2021, Current opinion in psychiatry.

Extracellular Vesicle Biomarkers Reveal Inhibition of Neuroinflammation by Infliximab in Association with Antidepressant Response in Adults with Bipolar Depression

Nelson B Rodrigues, T. Suppes, R. McIntyre, 2020, Cells.

Targeting cytokines in reduction of depressive symptoms: A comprehensive review

R. McIntyre, J. Rosenblat, E. Brietzke, 2018, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

Efficacy of dextromethorphan for the treatment of depression: a systematic review of preclinical and clinical trials

R. McIntyre, J. Rosenblat, R. Ho, 2021, Expert opinion on emerging drugs.

Peripheral inflammatory biomarkers define biotypes of bipolar depression

Nicole E. Carmona, T. Suppes, R. McIntyre, 2021, Biological Psychiatry.

A simplified 6-Item clinician administered dissociative symptom scale (CADSS-6) for monitoring dissociative effects of sub-anesthetic ketamine infusions.

Nelson B Rodrigues, R. McIntyre, M. Vinberg, 2020, Journal of affective disorders.

Factors influencing respirator use at work in respiratory patients.

I. Kudla, S. Tarlo, J. Rosenblat, 2011, Occupational medicine.

Real world effectiveness of repeated ketamine infusions for treatment-resistant depression with comorbid borderline personality disorder

Nelson B Rodrigues, R. McIntyre, J. Rosenblat, 2023, Psychiatry Research.

Real‐world effectiveness of repeated ketamine infusions for treatment‐resistant bipolar depression

Nelson B Rodrigues, R. McIntyre, J. Rosenblat, 2022, Bipolar disorders.

The effectiveness of repeated intravenous ketamine on depressive symptoms, suicidal ideation and functional disability in adults with major depressive disorder and bipolar disorder: Results from the Canadian Rapid Treatment Center of Excellence.

Nelson B Rodrigues, R. McIntyre, J. Rosenblat, 2020, Journal of affective disorders.

Safety and tolerability of IV ketamine in adults with major depressive or bipolar disorder: results from the Canadian rapid treatment center of excellence

Nelson B Rodrigues, R. McIntyre, J. Rosenblat, 2020, Expert opinion on drug safety.

Strategies to mitigate dissociative and psychotomimetic effects of ketamine in the treatment of major depressive episodes: a narrative review

R. McIntyre, J. Rosenblat, Ron Kakar, 2017, The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry.

Evidence supporting a mechanistic role of sirtuins in mood and metabolic disorders

R. McIntyre, J. Rosenblat, E. Brietzke, 2018, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

The Canadian Network for Mood and Anxiety Treatments (CANMAT) Task Force Report: Serotonergic Psychedelic Treatments for Major Depressive Disorder

R. Lam, S. Kennedy, R. McIntyre, 2022, Canadian journal of psychiatry. Revue canadienne de psychiatrie.

Potential differences in antidepressant effects of oral ketamine liquid suspension versus compounded capsules

J. Rosenblat, 2019, The British Journal of Psychiatry.

Depression and Disturbed Bone Metabolism: A Narrative Review of the Epidemiological Findings and Postulated Mechanisms.

A. Carvalho, R. McIntyre, J. Rosenblat, 2016, Current molecular medicine.

Efficacy of adjunctive infliximab vs. placebo in the treatment of anhedonia in bipolar I/II depression

Nicole E. Carmona, T. Suppes, R. McIntyre, 2020, Brain, Behavior, and Immunity.

The effect of repeated doses of intravenous ketamine on measures of workplace attendance and productivity in adults with major depressive and bipolar disorder: Results from the canadian rapid treatment center of excellence

Nelson B Rodrigues, R. McIntyre, J. Rosenblat, 2021, Psychiatry Research.

Association of SARS-CoV-2 Infection with Neurological Symptoms and Neuroimaging Manifestations in the Pediatric Population: A Systematic Review

R. McIntyre, J. Rosenblat, L. Moscote-Salazar, 2023, Research square.

Loneliness-based impaired reward system pathway: Theoretical and clinical analysis and application

Nelson B Rodrigues, R. McIntyre, J. Rosenblat, 2021, Psychiatry Research.

A Phase II, Open-Label Clinical Trial of Intranasal Ketamine for Depression in Patients with Cancer Receiving Palliative Care (INKeD-PC Study)

R. McIntyre, J. Rosenblat, Madeline Li, 2023, Cancers.

Dementia with Lewy bodies presenting as psychotic depression

J. Rosenblat, A. Flint, Joseph K Perera, 2017, The Australian and New Zealand journal of psychiatry.

Early symptomatic improvements as a predictor of response to repeated-dose intravenous ketamine: Results from the Canadian Rapid Treatment Center of Excellence

Nelson B Rodrigues, R. McIntyre, J. Rosenblat, 2020, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

The Effects of Ketamine on Cognition in Treatment-Resistant Depression: A Systematic Review and Priority Avenues for Future Research

Nelson B Rodrigues, R. McIntyre, J. Rosenblat, 2020, Neuroscience & Biobehavioral Reviews.

Antidepressant Medications and Weight Change: A Narrative Review

Nelson B Rodrigues, R. McIntyre, J. Rosenblat, 2020, Obesity.

Does Pharmacogenomic Testing Improve Clinical Outcomes for Major Depressive Disorder? A Systematic Review of Clinical Trials and Cost-Effectiveness Studies.

Roger S McIntyre, R. McIntyre, J. Rosenblat, 2017, The Journal of clinical psychiatry.

The acute antisuicidal effects of single-dose intravenous ketamine and intranasal esketamine in individuals with major depression and bipolar disorders: A systematic review and meta-analysis.

Nelson B Rodrigues, R. McIntyre, J. Rosenblat, 2020, Journal of psychiatric research.

Comparative efficacy of pharmacological treatments on measures of self-rated functional outcomes using the Sheehan Disability Scale in patients with major depressive disorder: a systematic review and network meta-analysis

R. McIntyre, J. Rosenblat, S. Zhan, 2021, CNS Spectrums.

Immune response to vaccination in adults with mental disorders: A systematic review

R. McIntyre, J. Rosenblat, R. Ho, 2022, Journal of Affective Disorders.

Leptin mediates improvements in cognitive function following treatment with infliximab in adults with bipolar depression

Nelson B Rodrigues, Nicole E. Carmona, R. McIntyre, 2020, Psychoneuroendocrinology.

Deficits of social cognition in bipolar disorder: Systematic review and meta‐analysis

R. McIntyre, K. Miskowiak, J. Rosenblat, 2021, Bipolar disorders.

Depression in the medically ill

M. Maes, A. Carvalho, R. McIntyre, 2019, The Australian and New Zealand journal of psychiatry.

Deconstructing Diabetes and Depression: Clinical Context, Treatment Strategies, and New Directions.

R. McIntyre, J. Rosenblat, J. Gregory, 2016, Focus.

An update on potential pharmacotherapies for cognitive impairment in bipolar disorder

R. McIntyre, J. Rosenblat, R. Mansur, 2023, Expert opinion on pharmacotherapy.

Predictors of Response to Ketamine in Treatment Resistant Major Depressive Disorder and Bipolar Disorder

R. McIntyre, J. Rosenblat, D. Cha, 2018, International journal of environmental research and public health.

Novel therapeutic targets in mood disorders: Pentoxifylline (PTX) as a candidate treatment

Nelson B Rodrigues, R. McIntyre, J. Rosenblat, 2020, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

The efficacy and safety of adjunctive intranasal esketamine treatment in major depressive disorder: a systematic review and meta-analysis

R. McIntyre, J. Rosenblat, Muhammad Youshay Jawad, 2022, Expert opinion on drug safety.

Antidepressant Effects of Psilocybin in the Absence of Psychedelic Effects.

R. McIntyre, J. Rosenblat, M. Husain, 2023, The American journal of psychiatry.

Does pre-treatment functioning influence response to intravenous ketamine in adults with treatment-resistant depression?

Nelson B Rodrigues, R. McIntyre, J. Rosenblat, 2021, Journal of affective disorders.

The effectiveness of ketamine on anxiety, irritability, and agitation: Implications for treating mixed features in adults with major depressive or bipolar disorder

Nelson B Rodrigues, T. Suppes, A. Fagiolini, 2020, Bipolar disorders.

Trace elements differences in the depression sensitive and resilient rat models.

J. Rosenblat, Bing Cao, Lailai Yan, 2020, Biochemical and biophysical research communications.

The emerging role of psilocybin and MDMA in the treatment of mental illness

Nelson B Rodrigues, R. McIntyre, J. Rosenblat, 2020, Expert review of neurotherapeutics.

Cognitive impairment as measured by the THINC-integrated tool (THINC-it): The association with self-reported anxiety in Major Depressive Disorder.

Nelson B Rodrigues, Nicole E. Carmona, R. McIntyre, 2018, Journal of affective disorders.

Targeting the immune system in the treatment of bipolar disorder

J. Rosenblat, 2019, Psychopharmacology.

The Efficacy of Psychostimulants in Major Depressive Episodes: A Systematic Review and Meta-Analysis

R. Lam, S. Kennedy, R. McIntyre, 2017, Journal of clinical psychopharmacology.

Novel therapeutic drug targets for bipolar disorder

J. Rosenblat, 2021 .

Indirect Calorimetry to Measure Metabolic Rate and Energy Expenditure in Psychiatric Populations: A Systematic Review

R. McIntyre, J. Rosenblat, R. Mansur, 2023, Nutrients.

Olanzapine and Samidorphan Combination Treatment: A Systematic Review.

R. McIntyre, J. Rosenblat, David Chen-Li, 2022, Journal of affective disorders.

Association of history of adverse childhood experiences with irritable bowel syndrome (IBS) in individuals with mood disorders

A. Carvalho, S. Kennedy, R. McIntyre, 2020, Psychiatry Research.

Pharmacological Treatment of Major Depressive Disorder

R. McIntyre, J. Rosenblat, 2020 .

Sex differences in ketamine's therapeutic effects for mood disorders: A systematic review

Nelson B Rodrigues, R. McIntyre, J. Rosenblat, 2022, Psychiatry Research.

Repetitive transcranial magnetic stimulation for cognitive function in adults with bipolar disorder: A pilot study.

Nelson B Rodrigues, R. McIntyre, J. Rosenblat, 2021, Journal of Affective Disorders.

Using early changes in cold cognition to predict response to vortioxetine in major depressive disorder

R. McIntyre, D. Blumberger, J. Rosenblat, 2020, Psychiatry Research.

Evaluating the role of orexins in the pathophysiology and treatment of depression: A comprehensive review

R. McIntyre, J. Rosenblat, E. Brietzke, 2019, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

Guidelines for the recognition and management of mixed depression.

A. Young, M. Fava, M. Thase, 2017, CNS spectrums.

Treatment recommendations for DSM-5–defined mixed features

R. McIntyre, J. Rosenblat, 2016, CNS Spectrums.

Treatment of mixed features in bipolar disorder

R. McIntyre, J. Rosenblat, 2016, CNS Spectrums.

Association of a low protein diet with depressive symptoms and poor health-related quality of life in CKD.

R. McIntyre, J. Rosenblat, R. Mansur, 2023, Journal of psychiatric research.

Depression, anxiety and post-traumatic stress during the 2022 Russo-Ukrainian war, a comparison between populations in Poland, Ukraine, and Taiwan

R. McIntyre, J. Rosenblat, R. Ho, 2023, Scientific Reports.

The meaningful change threshold as measured by the 16-item quick inventory of depressive symptomatology in adults with treatment-resistant major depressive and bipolar disorder receiving intravenous ketamine.

Nelson B Rodrigues, R. McIntyre, J. Rosenblat, 2021, Journal of affective disorders.

Serotonergic psychedelics for depression: What do we know about neurobiological mechanisms of action?

B. Mulsant, D. Blumberger, J. Rosenblat, 2023, Frontiers in Psychiatry.

A New Perspective on the Anti-Suicide Effects With Ketamine Treatment: A Procognitive Effect

R. McIntyre, J. Rosenblat, D. Cha, 2016, Journal of clinical psychopharmacology.

Immunity as a Common Risk Pathway for Psychiatric and Medical Comorbidity

R. McIntyre, J. Rosenblat, 2021, Immuno-Psychiatry.

The effect of intravenous ketamine on cognitive functions in adults with treatment-resistant major depressive or bipolar disorders: Results from the Canadian rapid treatment center of excellence (CRTCE)

Nelson B Rodrigues, R. McIntyre, J. Rosenblat, 2021, Psychiatry Research.

Does body mass index predict response to intravenous ketamine treatment in adults with major depressive and bipolar disorder? Results from the Canadian Rapid Treatment Center of Excellence

Nelson B Rodrigues, R. McIntyre, J. Rosenblat, 2020, CNS Spectrums.

Ecological momentary assessment of depressive symptoms using the mind.me application: Convergence with the Patient Health Questionnaire-9 (PHQ-9).

R. McIntyre, J. Rosenblat, E. Brietzke, 2021, Journal of psychiatric research.

Real-world effectiveness of repeated intravenous ketamine infusions for treatment-resistant depression in transitional age youth

Nelson B Rodrigues, R. McIntyre, J. Rosenblat, 2023, Journal of psychopharmacology.

The effectiveness of intravenous ketamine in adults with treatment-resistant major depressive disorder and bipolar disorder presenting with prominent anxiety: Results from the Canadian Rapid Treatment Center of Excellence

Nelson B Rodrigues, R. McIntyre, J. Rosenblat, 2020, Journal of psychopharmacology.

Ketamine monotherapy versus adjunctive ketamine in adults with treatment-resistant depression: Results from the Canadian Rapid Treatment Centre of Excellence.

Nelson B Rodrigues, R. McIntyre, J. Rosenblat, 2021, Journal of psychiatric research.

Letter to the Editor: Clinical versus statistical significance of pharmacogenomic-guided antidepressant therapy: What's really being measured and marketed?

R. McIntyre, S. Preskorn, J. Rosenblat, 2019, Journal of Psychiatric Research.

Factors That Impact Treatment Decisions: Results From an Online Survey of Individuals With Bipolar and Unipolar Depression.

R. McIntyre, G. Sachs, G. Simon, 2018, The primary care companion for CNS disorders.

Do sleep changes mediate the anti‐depressive and anti‐suicidal response of intravenous ketamine in treatment‐resistant depression?

Nelson B Rodrigues, R. McIntyre, J. Rosenblat, 2021, Journal of sleep research.

Is ketamine a litmus test for capacity in assisted dying with depression?

J. Rosenblat, Madeline Li, 2020, Psycho-oncology.

Perceived sleep quality predicts cognitive function in adults with major depressive disorder independent of depression severity.

Nicole E. Carmona, R. McIntyre, J. Rosenblat, 2019, Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists.

Evaluating Anhedonia as a risk factor in suicidality: A meta-analysis.

R. McIntyre, J. Rosenblat, R. Ho, 2022, Journal of psychiatric research.

The influence of prescriber and patient gender on the prescription of benzodiazepines: evidence for stereotypes and biases?

R. McIntyre, J. Rosenblat, R. Mansur, 2020, Social Psychiatry and Psychiatric Epidemiology.

Effectiveness of intravenous ketamine in mood disorder patients with a history of neurostimulation

Nelson B Rodrigues, R. McIntyre, J. Rosenblat, 2020, CNS Spectrums.

The Prevalence of Suicidal Behaviour in Fibromyalgia Patients

Nelson B Rodrigues, R. McIntyre, J. Rosenblat, 2020, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

Characterizing amino-acid biosignatures amongst individuals with schizophrenia: a case–control study

R. McIntyre, J. Rosenblat, D. Cha, 2018, Amino Acids.

An App-Based Digit Symbol Substitution Test for Assessment of Cognitive Deficits in Adults With Major Depressive Disorder: Evaluation Study

Nelson B Rodrigues, R. McIntyre, B. Fehnert, 2022, JMIR mental health.

Revising Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, criteria for the bipolar disorders: Phase I of the AREDOC project

M. Alda, J. Amsterdam, A. Young, 2018, The Australian and New Zealand journal of psychiatry.

Changes in insulin resistance following antidepressant treatment mediate response in major depressive disorder

R. McIntyre, J. Rosenblat, R. Mansur, 2022, Journal of psychopharmacology.

Insulin resistance is associated with deficits in hedonic, self-reported cognitive, and psychosocial functional response to antidepressant treatment in individuals with major depressive disorder.

Nelson B Rodrigues, R. McIntyre, J. Rosenblat, 2020, Journal of affective disorders.

Pharmacodynamic and pharmacokinetic evaluation of buprenorphine + samidorphan for the treatment of major depressive disorder

R. McIntyre, J. Rosenblat, R. Ho, 2018, Expert opinion on drug metabolism & toxicology.

Biomarkers of ketamine's antidepressant effect: An umbrella review.

R. McIntyre, J. Rosenblat, R. Ho, 2022, Journal of affective disorders.

A Systematic review of the validity of screening depression through Facebook, Twitter, Instagram, and Snapchat.

R. McIntyre, J. Rosenblat, R. Mansur, 2021, Journal of affective disorders.

Predicting outcome with Intranasal Esketamine treatment: A machine-learning, three-month study in Treatment-Resistant Depression (ESK-LEARNING)

L. Marzetti, G. Di Lorenzo, R. McIntyre, 2023, Psychiatry Research.

Psilocybin for treatment-resistant depression without psychedelic effects: study protocol for a 4-week, double-blind, proof-of-concept randomised controlled trial

B. Mulsant, W. Wang, D. Blumberger, 2023, BJPsych Open.

Are Antidepressants Harmful in the “General Population”?

R. McIntyre, J. Rosenblat, Sarah K Smith, 2018, Psychotherapy and Psychosomatics.

Role of Proinflammatory Cytokines in Dopaminergic System Disturbances, Implications for Anhedonic Features of MDD.

R. McIntyre, W. Swardfager, J. Rosenblat, 2017, Current pharmaceutical design.

Oral ketamine for depression: An updated systematic review

R. McIntyre, J. Rosenblat, R. Mansur, 2023, The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry.

Predicting outcome with Intranasal Esketamine treatment: A machine-learning, three-month study in Treatment-Resistant Depression (ESK-LEARNING)

L. Marzetti, G. Di Lorenzo, R. McIntyre, 2023, Psychiatry Research.

Characterizing amino-acid biosignatures amongst individuals with schizophrenia: a case–control study

R. McIntyre, J. Rosenblat, D. Cha, 2018, Amino Acids.

Medical comorbidity in bipolar disorder: The link with metabolic-inflammatory systems.

R. McIntyre, J. Rosenblat, Ron Kakar, 2017, Journal of affective disorders.

Effects of infliximab on brain neurochemistry of adults with bipolar depression.

Nelson B Rodrigues, Nicole E. Carmona, T. Suppes, 2020, Journal of Affective Disorders.

Intravenous ketamine for postmenopausal women with treatment-resistant depression: Results from the Canadian Rapid Treatment Center of Excellence.

Nelson B Rodrigues, R. McIntyre, J. Rosenblat, 2020, Journal of psychiatric research.

A New Perspective on the Anti-Suicide Effects With Ketamine Treatment: A Procognitive Effect

R. McIntyre, J. Rosenblat, D. Cha, 2016, Journal of clinical psychopharmacology.

Cognitive impairment as measured by the THINC-integrated tool (THINC-it): Association with psychosocial function in major depressive disorder.

Nicole E. Carmona, B. Baune, R. Lam, 2017, Journal of affective disorders.

The bidirectional association of nonalcoholic fatty liver disease with depression, bipolar disorder, and schizophrenia

R. McIntyre, J. Rosenblat, R. Mansur, 2022, CNS Spectrums.

Ketamine for bipolar depression: an updated systematic review

J. Rosenblat, R. Mansur, David Chen-Li, 2023, Therapeutic advances in psychopharmacology.

Beyond Psilocybin: Reviewing the Therapeutic Potential of Other Serotonergic Psychedelics in Mental and Substance Use Disorders.

B. Mulsant, D. Blumberger, J. Rosenblat, 2023, Journal of psychoactive drugs.

Strategies to mitigate dissociative and psychotomimetic effects of ketamine in the treatment of major depressive episodes: a narrative review

R. McIntyre, J. Rosenblat, Ron Kakar, 2016, The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry.

Assessing the Effects of Metabolic Disruption, Body Mass Index and Inflammation on Depressive Symptoms in Post-COVID-19 Condition: A Randomized Controlled Trial on Vortioxetine.

J. Rosenblat, Mehala Subramaniapillai, Lee Phan, 2024, Advances in therapy.

Impacts of metabolic disruption, body mass index and inflammation on cognitive function in post-COVID-19 condition: a randomized controlled trial on vortioxetine

J. Rosenblat, Mehala Subramaniapillai, Lee Phan, 2024, Annals of general psychiatry.

Association between fatigue and depressive symptoms in persons with post-COVID-19 condition: a post hoc analysis.

J. Rosenblat, Mehala Subramaniapillai, Lee Phan, 2024, Current medical research and opinion.

Treatment‐resistant depression: definition, prevalence, detection, management, and investigational interventions

A. Nierenberg, M. Vinberg, J. Rosenblat, 2023, World psychiatry : official journal of the World Psychiatric Association.

The rapid antidepressant effectiveness of repeated dose of intravenous ketamine and intranasal esketamine: A post-hoc analysis of pooled real-world data.

J. Rosenblat, R. Mansur, M. Di Nicola, 2023, Journal of affective disorders.

Psychotropic Drug-Related Weight Gain and Its Treatment.

J. Rosenblat, R. Mansur, K. Teopiz, 2024, The American journal of psychiatry.